Загрузка...
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
Prodrug activation gene therapy is a developing approach to cancer treatment, whereby prodrug-activating enzymes are expressed in tumour cells. After administration of a non-toxic prodrug, its conversion to cytotoxic metabolites directly kills tumour cells expressing the activating enzyme, whereas t...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2690450/ https://ncbi.nlm.nih.gov/pubmed/19455141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605094 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|